On May 19, 2022, Silo Pharma (OTCQB: SILO) announced that The Translational Psychedelic Research (“TrPR”) Program at UCSF (University of California San Francisco) had “successfully dosed [with psilocybin] patients suffering from Parkinson’s disease.” TrPR connects researchers and medical professionals studying how psychedelics, including psilocybin, ketamine, etc., affect brain functions and other organ systems. Silo Pharma […]

J.D. Power survey reports range was factor most cited in deciding what EV to buy Mullen is making significant strides toward producing vehicles that feature some of the longest ranges available in the EV space Recognizing the critical role of battery and range in the success of an EV, Mullen is exploring other advanced battery […]

Study shows that COVID-19 pandemic has affected mental health of 59% of U.S. population, intensifying already-serious issue CYBN-sponsored feasibility study indicates ketamine-induced changes in brain’s functional connectivity persisted for several days after receiving the substance Kernel Flow pivotal in developing most accurate, effective treatment regimens for patients The challenges associated with mental-health issues are rising, […]

Odyssey boasts a diverse development portfolio spanning both pharmaceutical candidates and medical devices The company is evaluating PRV-002 for the treatment of concussion, a dramatically underserved indication that currently has no FDA-approved drug With PRV-001, Odyssey aims to receive Orphan Drug designation, which could potentially accelerate its pathway to FDA approval and provide seven years […]

Hosted by CoinDesk, the 2022 Consensus festival is slated for June 9-12, 2022, in Austin, Texas The festival features 15,000+ attendees, 400+ speakers, and 250+ event sponsors, catering to all sides of blockchain, crypto, Web3, NFTs and the Metaverse Web3 is the future of the internet – creating a decentralized technology that removes the control […]

A key to becoming “irreplaceable” is to communicate clearly, Inc. article suggests Nowigence believes the capability to communicate clearly can be found in its high-proprietary, cloud-based knowledge management tool: Pluaris Pluaris reads and analyzes information across the internet 24/7, then organizes and optimizes gathered data for storage, analysis, synthesis and retrieval As companies — and individuals […]

Acquisition of 85,000-square-foot West Virginia manufacturing campus is key milestone in company’s vision to become household name Facility checks all boxes company wanted in first design and manufacturing location Kronos is focused on designing and manufacturing next-generation wellness consumer electronics products and PPE solutions A plan started more than two years ago by Kronos Advanced […]

Legislative changes driven by public policy commitment to slashing greenhouse emissions are driving increased demand for renewable natural gas (“RNG”) RNG generation avoids toxic emissions of methane, a greenhouse gas with a warming potential 25–34 times greater than Carbon Dioxide EverGen, Canada’s established renewable natural gas producer, appears ready to act on this rising market […]

Lexaria is a biotechnology company focused on licensing its proprietary DehydraTECH(TM) technology The DehydraTECH technology has been proven to increase the bioavailability, speed of onset and brain absorption of APIs, and improve customer experiences by masking unwanted tastes Lexaria has 25 patents granted worldwide and is pursuing numerous other pending patent applications The company operates […]

New York’s recreational and medical marijuana market is poised for historical growth amid rising public and political support for increased cultivation in the tri-state area. The Cannabis World Congress & Business Exposition (“CWCBExpo”), set to take place at New York City’s Javits Convention Center, Hall 3A on June 2-4, 2022, is the ideal forum for exploring industry […]